Category: Dangerous Drugs
New Mexico Dangerous Drugs – FDA Conflicts of Interest Compromise Our Safety
|
|
Last Modified
on
Mar 16, 2024
Recent allegations of research collaboration between the FDA’s top drug official – Dr. Janet Woodcock – and a pharmaceutical company underscore the potential for conflicts of interests and the high stakes involved in drug marketing. In fact, over the years the FDA has been involved in many conflicts of interest involving dangerous drugs. In August… read more
New Reports Link Avandia To Increased Risk Of Heart Attack
|
|
Last Modified
on
Mar 16, 2024
This past week new studies reported that Avandia poses a substantially greater risk of heart attacks for its users. Avandia is a diabetes drug prescribed to thousands of diabetics in New Mexico and throughout the United States. In one study, published by the AMA, researchers studied more than 227,000 people who took Avandia and found… read more
DANGEROUS DRUG – Reglan
|
|
Last Modified
on
Mar 16, 2024
Reglan is a prescription drug pushed by pharmaceutical companies to patients to treat Gastroesophageal reflux (GER) Gastroesophageal reflux disease (GERD). Many studies dating back from the 1970s have shown that Reglan is ineffective in resolving GER and GERD. A 2006 study published in Nature Clinical Practice: Gastroenterology & Hepatology concluded that “the evidence base for… read more
American Dangerous Drug Trials Being Conducted Overseas
|
|
Last Modified
on
Mar 16, 2024
A recent investigative article has disclosed some scary statistics. Even with FDA approval, prescription drugs kill nearly 200,000 Americans each year. As a result of consumer backlash and the raised awareness of the potential risks of dangerous drugs such as Avandia, Reglan, and Darvon/Darvocet, many U.S. drug companies have now moved their clinical trials overseas… read more
Avandia Clinical Trials Partially Stopped
|
|
Last Modified
on
Mar 16, 2024
Last week the Food and Drug Administration (FDA) advisory panel recommended that Avandia – a popular diabetes drug linked to a higher risk of heart attack – contain either stronger warning labels or restrict its use. Avandia is developed and manufactured by GlaxoSmithKline. In addition to a well-documented increased risk of heart attack, Avandia has… read more
Can Parents Sue For A Vaccine’s Design Defect?
|
|
Last Modified
on
Mar 16, 2024
Last week the United States Supreme Court heard arguments concerning whether the parents of a girl who became sick shortly after being vaccinated against diphtheria, tetanus, and pertussis can sue the vaccine’s manufacturer. The parents allege a design defect. Nearly 5,000 potential lawsuits may result if the court allows the parents to sue, asserting a… read more
Study Reveals Propecia May Cause Persistent Sexual Dysfunction
|
|
Last Modified
on
Mar 16, 2024
Recent reports have linked finasteride – marketed as Propecia – with persistent and possibly irreversible sexual dysfunction. Propecia, which treats hair loss, works by decreasing the conversion of testosterone to dihydrotestosterone, a hormone that causes hair loss. In fact, doctors have known for years that Propecia has been linked to sexual problems including impotence, but… read more
Supreme Court Agrees To Hear Generic Reglan Drug Label Suit
|
|
Last Modified
on
Mar 16, 2024
The U.S. Supreme Court has agreed to hear arguments over whether generic drug makers can be sued for the failure to warn about dangerous side effects on their drug label even when they follow federal rules. In PLIVA, Inc. v. Mensing a woman took metoclopramide – the generic equivalent of Reglan – for four years… read more
Darvon/Darvocet Pulled From The Market
|
|
Last Modified
on
Mar 16, 2024
Last week, the FDA finally pulled propoxyphene – sold as Darvon and Darvocet – from the U.S. market. For nearly 50 years concerns have been raised over the side effects of Darvon/Darvocet usage, including its toxicity even at low levels and its highly addictive properties. Additionally, it has not been shown to be very effective… read more
Topamax Linked To Birth Defects
|
|
Last Modified
on
Mar 16, 2024
The New York Times reports that Topamax, manufactured by Johnson & Johnson, has been linked to birth defects, such as a higher risk of developing cleft lips and palates, genital malformations, and cranial malformations. Topamax is an anti-seizure and migraine drug used in the treatment of migraines and epilepsy. It is also used in the… read more
Knowledge Experience Compassion Service 
